pulmonary

Dr. Wayne Morgan has been conducting research on children with asthma who live in the inner city. His reseach was published in The New England Journal of Medicine.

In Arizona we have nearly twice the national average of kids with asthma. Pediatricians at the Steele Center and the Arizona Respiratory Sciences Center are studying how genes determine a patient's response to asthma treatment.

The conventional therapy for children with severe asthma usually is a form of abuterol in an aerosolized form. Unfortunately, some children do not respond well to this type of treatment, which may put them at higher risk for acute asthma attacks. UA researchers have demonstrated that the receptors in a child's lung that trigger the bronchi to dilate vary according to the genetic makeup of the child. Knowing which child will respond to which treatment before an asthma attack could mean improved treatment for children with asthma the world over.

The Pediatric Pulmonology section of the UA Department of Pediatrics has been named a Pediatric Pulmonary Center (PPC) by the Program of the Maternal and Child Health Bureau. We are the first and only center of this type in the western U.S. (including Arizona, California, Nevada, and Hawaii). The PPC designation means that our pediatric pulmonologists will be training medical professionals from all the states in the region on improved therapies for children with chronic lung disease. Led by Wayne Morgan, MD, the PPC will mean enhanced care for thousands of children with asthma, cystic fibrosis and bronchiolopulmonary dysplasia (BPD).